Vivani Medical Mergers and Acquisitions Presentation Deck
Current Drug
Adherence Challenge
"Drugs don't work in people that don't take them"
NPM-119 Designed to Enable 100%
Adherence through Implant Duration
• Orals and injectables do not guarantee adherence
• Approximately 50% of patients do not meet
glycemic targets primarily due to adherence
Dual Incentive to Adopt Technology that
Improves Adherence
Pharmaceutical revenue is increased
• Healthcare costs are decreased
.
*NPM-119 - investigational candidate, not approved in any market
Real-world Adherence
100%
75%
50%
25%
0%
Real-World Adherence of Select Drugs
Januvia
DPP-4 inhibitors,
daily pills
Polonsky et al., 2016
Trulicity
GLP-1 weekly
injections
Modyet al., 2018
Invokana
SGLT-2
daily pills
Cai et al., 2017
* NPM-119 designed to enable 100% adherence.
NPM-119*
GLP-1
implant every
6 months
13View entire presentation